Marcel Yotebieng1, Annelies Van Rie, Harry Moultrie, Tammy Meyers. 1. Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA. yotebieng@unc.edu
Abstract
OBJECTIVES: Construct percentile curves for 6-month gain in weight, height, CD4 cell count, and CD4 percentage (CD4%) in children initiating ART, and to assess the association between lower percentiles and subsequent ART responses. DESIGN: Cohort of 1394 HIV-infected children initiating ART between April 2004 and March 2008, Johannesburg, South Africa METHODS: The generalized additive model for location, scale, and shape was used to construct percentile curves for 6-month gain in weight, height, CD4 cell count, and CD4%. Cox proportional models were used to assess the association between lower percentiles of each distribution and death, virological suppression, and treatment failure between 6 to 36 months post-ART initiation. RESULTS: Lower percentiles for gain in weight, CD4, and CD4% count after 6 months of ART, but not height, were associated with poor subsequent treatment outcomes independent of baseline characteristics, with increasing strength of association as percentiles decreased. Age-specific 6-month post-ART weight gain in our cohort was substantially higher compared with 6-month weight gain in non-HIV-infected American children of the Fels Institute cohort and the attained weight-for-age at 6 months post-ART plotted on WHO weight-for-age growth charts were not associated with subsequent treatment outcomes. CONCLUSION: Gain in CD4% in the first 6 months of ART was the best predictor of poor subsequent ART outcomes. In areas with limited access to CD4%, weight gain post-ART using our newly developed reference distributions for HIV-infected children on ART is a good alternative to CD4%, and clearly superior to the commonly used 'Road-to-Health' weight-for-age charts.
OBJECTIVES: Construct percentile curves for 6-month gain in weight, height, CD4 cell count, and CD4 percentage (CD4%) in children initiating ART, and to assess the association between lower percentiles and subsequent ART responses. DESIGN: Cohort of 1394 HIV-infectedchildren initiating ART between April 2004 and March 2008, Johannesburg, South Africa METHODS: The generalized additive model for location, scale, and shape was used to construct percentile curves for 6-month gain in weight, height, CD4 cell count, and CD4%. Cox proportional models were used to assess the association between lower percentiles of each distribution and death, virological suppression, and treatment failure between 6 to 36 months post-ART initiation. RESULTS: Lower percentiles for gain in weight, CD4, and CD4% count after 6 months of ART, but not height, were associated with poor subsequent treatment outcomes independent of baseline characteristics, with increasing strength of association as percentiles decreased. Age-specific 6-month post-ARTweight gain in our cohort was substantially higher compared with 6-month weight gain in non-HIV-infected American children of the Fels Institute cohort and the attained weight-for-age at 6 months post-ART plotted on WHO weight-for-age growth charts were not associated with subsequent treatment outcomes. CONCLUSION: Gain in CD4% in the first 6 months of ART was the best predictor of poor subsequent ART outcomes. In areas with limited access to CD4%, weight gain post-ART using our newly developed reference distributions for HIV-infectedchildren on ART is a good alternative to CD4%, and clearly superior to the commonly used 'Road-to-Health' weight-for-age charts.
Authors: J A Englund; C J Baker; C Raskino; R E McKinney; B Petrie; M G Fowler; D Pearson; A Gershon; G D McSherry; E J Abrams; J Schliozberg; J L Sullivan Journal: N Engl J Med Date: 1997-06-12 Impact factor: 91.245
Authors: M W Kline; R B Van Dyke; J C Lindsey; M Gwynne; M Culnane; R E McKinney; S Nichols; W G Mitchell; R Yogev; N Hutcheon Journal: Pediatrics Date: 1998-02 Impact factor: 7.124
Authors: S S Bakshi; P Britto; E Capparelli; L Mofenson; M G Fowler; S Rasheed; D Schoenfeld; B Zimmer; Y Frank; R Yogev; E Jimenez; M Salgo; G Boone; S G Pahwa Journal: J Infect Dis Date: 1997-05 Impact factor: 5.226
Authors: Carolyn Bolton-Moore; Mwangelwa Mubiana-Mbewe; Ronald A Cantrell; Namwinga Chintu; Elizabeth M Stringer; Benjamin H Chi; Moses Sinkala; Chipepo Kankasa; Craig M Wilson; Catherine M Wilfert; Albert Mwango; Jens Levy; Elaine J Abrams; Marc Bulterys; Jeffrey S A Stringer Journal: JAMA Date: 2007-10-24 Impact factor: 56.272
Authors: R E McKinney; G M Johnson; K Stanley; F H Yong; A Keller; K J O'Donnell; P Brouwers; W G Mitchell; R Yogev; D W Wara; A Wiznia; L Mofenson; J McNamara; S A Spector Journal: J Pediatr Date: 1998-10 Impact factor: 4.406
Authors: I Maro; T Lahey; T MacKenzie; L Mtei; M Bakari; M Matee; K Pallangyo; C F von Reyn Journal: Int J Tuberc Lung Dis Date: 2010-11 Impact factor: 2.373
Authors: Thomas Gsponer; Ralf Weigel; Mary-Ann Davies; Carolyn Bolton; Harry Moultrie; Paula Vaz; Helena Rabie; Karl Technau; James Ndirangu; Brian Eley; Daniela Garone; Maureen Wellington; Janet Giddy; Jochen Ehmer; Matthias Egger; Olivia Keiser Journal: Pediatrics Date: 2012-09-17 Impact factor: 7.124
Authors: Catherine G Sutcliffe; Janneke H van Dijk; Bornface Munsanje; Francis Hamangaba; Pamela Sinywimaanzi; Philip E Thuma; William J Moss Journal: BMC Infect Dis Date: 2011-03-01 Impact factor: 3.090